Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Infusion Versus Intermittent Administration of Meropenem in Critically Ill Patients: A Multicenter Randomized Double Blind Trial

NCT03452839 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT03452839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Infusion Versus Intermittent Administration of Meropenem in Critically Ill Patients: A Multicenter Randomized Double Blind Trial
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Phase 4
Overall status
Completed
Start date
June 5, 2018
Completion date
December 1, 2022
Enrollment
607 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic resistant infection, critical illness